Prospective Observational Study Assessing Treatment and Outcomes of Patients With Prediabetes
NCT ID: NCT01869101
Last Updated: 2013-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
560 participants
OBSERVATIONAL
2013-06-30
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Blood Glucose Levels and Gut Microbiota in Healthy Individuals
NCT01892956
Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes
NCT00805506
Diabetes Prevention in Women With a Recent History of Gestational Diabetes (Focus Groups)
NCT01102530
Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
NCT00569907
Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
NCT03695913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of prediabetes based on hemoglobin A1C and/or fasting plasma glucose
* Established patient of Principal Investigator's clinical practice
* BMI greater than or equal to 25 kg/m2
* Physically able to participate in a diabetes prevention program
Exclusion Criteria
* Is pregnant or is planning to become pregnant in the next 6 months
* Is currently taking a medication prescribed for diabetes prevention
* Is currently enrolled in a formal diabetes prevention or weight loss program
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tethys Bioscience, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan P. Frias, M.D.
Role: STUDY_DIRECTOR
Tethys Bioscience
David G Marrero, Ph.D.
Role: STUDY_CHAIR
Indiana University School of Medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TET2013-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.